International and Racial Differences in Mineral and Bone Disorder Markers and Treatments Over the First 5 Years of Hemodialysis in the Dialysis Outcomes and Practice Patterns Study
Rationale & Objective: Normalization of parathyroid hormone (PTH), serum calcium, and phosphorus levels may prevent coronary and bone disease in hemodialysis (HD) patients. We describe the trajectory of these mineral bone disorder parameters and treatments during the first 5 years of HD by inter...
Main Authors: | Kevin Chan, Angelo Karaboyas, Hal Morgenstern, Bruce M. Robinson, Friedrich K. Port, Stefan H. Jacobson, Masafumi Fukagawa, Yvonne Meier, Philipp A. Csomor, Ronald L. Pisoni |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-05-01
|
Series: | Kidney Medicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590059519300342 |
Similar Items
-
Mineral and bone disorder management in hemodialysis patients: comparing PTH control practices in Japan with Europe and North America: the Dialysis Outcomes and Practice Patterns Study (DOPPS)
by: Suguru Yamamoto, et al.
Published: (2018-10-01) -
Self-reported Pruritus and Clinical, Dialysis-Related, and Patient-Reported Outcomes in Hemodialysis PatientsPlain-Language Summary
by: Nidhi Sukul, et al.
Published: (2021-01-01) -
Perceptions about the dialysis modality decision process among peritoneal dialysis and in-center hemodialysis patients
by: Jarcy Zee, et al.
Published: (2018-10-01) -
Predictors of cinacalcet discontinuation and reinitiation in hemodialysis patients: results from 7 European countries
by: Douglas S. Fuller, et al.
Published: (2019-05-01) -
Estimating the Fraction of First-Year Hemodialysis Deaths Attributable to Potentially Modifiable Risk Factors: Results from the DOPPS
by: Karaboyas A, et al.
Published: (2020-01-01)